Parkman Healthcare Partners’s Annexon ANNX Stock Holding History

Parkman Healthcare Partners’s Portfolio ANNX Stock Details ANNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.73M	Buy	674,013 +72,811	+12%	+$410K	0.39%	70
2025 Q4	$3.02M	Buy	601,202 +195,249	+48%	+$746K	0.29%	80
2025 Q3	$1.24M	Buy	405,953 +1,759	+0.4%	+$4.37K	0.13%	84
2025 Q2	$970K	Buy	404,194 +52,758	+15%	+$106K	0.11%	84
2025 Q1	$678K	Buy	351,436 +20,587	+6%	+$68.5K	0.08%	87
2024 Q4	$1.7M	Buy	330,849 +2,236	+0.7%	+$13.8K	0.23%	78
2024 Q3	$1.95M	Buy	328,613 +1,768	+0.5%	+$10.5K	0.25%	75
2024 Q2	$1.6M	Sell	326,845 -19,842	-6%	-$103K	0.21%	77
2024 Q1	$2.49M	Buy	+346,687	New	+$1.8M	0.31%	79

Other funds holding ANNX

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Parkman Healthcare Partners's ANNX Position: Q1 2026 in Review

Parkman Healthcare Partners increased its Annexon (ANNX) stake by 12% in Q1 2026, buying an estimated $410K and bringing the position to 674,013 shares worth $3.73M. The position accounts for 0.39% of the portfolio, ranked #70.

Parkman Healthcare Partners first reported a position in ANNX in Q1 2024 and has held it in 9 quarters since. 217 funds tracked by Wall St. Rank hold ANNX as of Q1 2026.

Parkman Healthcare Partners held 674,013 shares of Annexon worth $3.73M as of Q1 2026.
Parkman Healthcare Partners bought 72,811 Annexon shares in Q1 2026, an estimated $410K.
Annexon made up 0.39% of Parkman Healthcare Partners's portfolio in Q1 2026, its #70 holding.
Parkman Healthcare Partners first reported a position in Annexon in Q1 2024 and has held it in 9 quarters since.
217 funds tracked by Wall St. Rank held Annexon as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.